+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0Months - 24Months
All Genders
ID06703918

Retrospective Study of Clostridium difficile Infection and Biomarkers in Infants up to 2 Years

Led by First People's Hospital of Hangzhou · Updated on 2024-11-25

150

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to understand Clostridium difficile infection CDI in infants up to 2 years old by studying past medical data and patient questionnaires. It focuses on identifying how common CDI is in this group, what risk factors increase the chance of infection, and what biomarkers can help detect the infection early. This observational study hopes to improve diagnosis and treatment for young children affected by CDI. The study compares two groups infants diagnosed with CDI and those without the infection. Researchers will analyze medical records and questionnaire data from both groups to find differences in epidemiological characteristics and biomarkers linked to CDI. There are no new treatments given, as this is a retrospective review of existing information. Participants involvement includes the use of their historical medical records and questionnaire responses to identify high-risk factors and biomarkers related to CDI. The main outcome measured is the number of infants with identified risk factors for CDI over a review period of up to 12 months after diagnosis. Additional outcomes include identifying biomarkers and validating a mouse model for CDI research. The study spans data collection and analysis up to 18 months.

CONDITIONS

Brief Title

Study on Clostridium Difficile Infection in Infants

Research Team

L

Li Qian Wang, Master of Medicine

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here